Stock PRTA PROTHENA CORPORATION PLC
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
21.68 USD -3.43% Intraday chart for Prothena Corporation plc +7.27% -40.34%
May. 28 Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License MT
May. 28 Prothena Announces Bristol Myers Squibb Opt-In for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRTA Stock
  4. News Prothena Corporation plc
  5. MarketScreener Editorial Features